The Wall Street Journal-20080118-Earnings Digest -- Ranbaxy Laboratories Ltd-- Low Foreign-Exchange Gain Holds Down Net Profit

Return to: The_Wall_Street_Journal-20080118

Earnings Digest -- Ranbaxy Laboratories Ltd.: Low Foreign-Exchange Gain Holds Down Net Profit

Full Text (89  words)

Ranbaxy Laboratories Ltd. said fourth-quarter consolidated net profit rose marginally from a year earlier, as it recorded a lower foreign-exchange gain. Ranbaxy, India's largest pharmaceuticals company by sales, said consolidated net profit rose to 1.88 billion rupees ($47.9 million) from 1.86 billion rupees. Net sales rose 5.1% to 17.95 billion rupees from 17.08 billion rupees. It recorded a foreign-exchange gain of 109 million rupees, down from 460 million rupees. For the full year, the company recorded net profit of 7.9 billion rupees on net sales of 66.35 billion rupees.